NN:EURONEXT AMSTERDAMNN Group N.V. Analysis

The stock is trading at $13.11, well below its 20‑day SMA of 14.33, 50‑day SMA of 17.68, and 200‑day SMA of 16.44, indicating a bearish positioning on the chart. RSI sits at 36, suggesting modest oversold pressure but not yet extreme. The MACD histogram is positive (0.12) while the line remains above the signal, giving a short‑term bullish signal. Volatility over the past 30 days is elevated at roughly 62 %, and the beta of around 1.4 points to higher‑than‑market swing. The price is perched just above the identified support of $12.03 and well under the resistance near $17.72, leaving limited upside in the near term. Volume has remained stable, providing enough liquidity for short‑term trades.
Fundamentally, the company is in distress: revenue has contracted 35 % YoY to $4.0 M, gross margin is a negative 101 %, and operating losses exceed $65 M, driving a negative free cash flow of $19.8 M. Balance‑sheet metrics show $143 M of cash offset by $282 M of debt and a negative book value per share of –$0.66, resulting in a price‑to‑book of –19.8 and a price‑to‑sales of 444, which are far above industry norms. The PE ratio is negative and the forward PE sits at –24.7, confirming that earnings are currently non‑existent. No dividend is paid, and the payout sustainability metric is therefore false. Analysts (3) have a “strong buy” consensus with a median target of $29, implying a potential upside of over 150 % relative to the current price, yet the underlying financial health casts serious doubt on that optimism. In sum, the technical picture offers a modest short‑term bounce, but the company’s severe earnings and balance‑sheet challenges render it fundamentally overvalued and high‑risk.